MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, CTKB made $44,135K in revenue. -$18,866K in net income. Net profit margin of -42.75%.

Income Overview

Revenue
$44,135K
Net Income
-$18,866K
Net Profit Margin
-42.75%
Unit: Thousand (K) dollars
Revenue Breakdown
    • US
    • EMEA
    • Asia Pacific
    • Other
Revenue Breakdown
    • Sales Channel Directly To Consum...
    • Sales Channel Through Intermedia...
Revenue Breakdown
    • Biotechnology Pharmaceutical Dis...
    • Academia And Government
Revenue Breakdown
    • Product
    • Service

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Total revenue, net
44,135 62,141 52,293 45,602
Service
---6,814
Product
---14,921
Total cost of sales
22,881 29,256 24,742 21,735
Gross profit
21,254 32,885 27,551 23,867
Research and development
9,604 8,961 8,956 8,826
Sales and marketing
11,646 13,131 11,666 12,134
General and administrative
18,467 16,386 16,121 13,531
Total operating expenses
39,717 38,478 36,743 34,491
Loss from operations
-18,463 -5,593 -9,192 -10,624
Interest expense
262 -725 494 414
Interest income
787 580 573 555
Other income, net
565 257 1,344 3,708
Total other income, net
1,090 1,562 1,423 3,849
Loss before income taxes
-17,373 -4,031 -7,769 -6,775
Provision for income taxes
1,493 40,045 -2,291 -1,192
Net loss
--44,076* -5,478 -
Less net loss allocated to noncontrolling interests
-0* --
Net loss
-18,866 ---5,583
Net loss attributable to common stockholders, diluted
--44,076 --
Net loss, basic
-18,866 --5,478 -5,583
Basic Average Shares
128,704,934 128,162,122 127,547,859 126,934,294
Diluted Average Shares
128,704,934 128,162,122 127,547,859 126,934,294
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss, basic-$18,866K (-65.46%↓ Y/Y)Net loss-$18,866K Interest income$787K (54.92%↑ Y/Y)Other income, net$565K (-83.82%↓ Y/Y)US$24,387K (31.57%↑ Y/Y)EMEA$10,765K (-6.93%↓ Y/Y)Asia Pacific$7,751K (-12.82%↓ Y/Y)Other$1,232K (-50.02%↓ Y/Y)Loss before incometaxes-$17,373K Provision for income taxes$1,493K (997.79%↑ Y/Y)Total other income,net$1,090K (-70.61%↓ Y/Y)Total revenue, net$44,135K (6.46%↑ Y/Y)Interest expense$262K (-9.97%↓ Y/Y)Loss from operations-$18,463K (-23.29%↓ Y/Y)Gross profit$21,254K (5.44%↑ Y/Y)Total cost of sales$22,881K (7.42%↑ Y/Y)Total operatingexpenses$39,717K (13.05%↑ Y/Y)General andadministrative$18,467K (43.18%↑ Y/Y)Sales and marketing$11,646K (-6.90%↓ Y/Y)Research and development$9,604K (-1.24%↓ Y/Y)

Cytek Biosciences, Inc. (CTKB)

Cytek Biosciences, Inc. (CTKB)